#invest #stocks
#retweet with more #investors
Must read this blog for more

More from Iex

IEX Indian Energy Exchange - ⭕️⭕️

although a must-have portfolio stock. Faced resistance right at the upper channel boundary. Volumes high. Any retracement back to the lower boundary will be an opportunity to accumulate. https://t.co/5uDsUXsbPP

IEX - the resistance turning support. Kindly review, please. @nishkumar1977 @suru27 @rohanshah619 @indian_stockss @sanstocktrader @BissaGauravB @RajarshitaS @PAVLeader @Rishikesh_ADX @VijayThk @Investor_Mohit @TrendTrader85 pic.twitter.com/7CCzmee5If
— Steve Nison (@nison_steve) December 18, 2020

$Waves_Perception(Dinesh Patel) \u092e\u0948\u0902Schedule Tribes)$

Waves_Perception(Dines...
@idineshptl

#IEX-956

#Fibonacci extension 11.077%(1089)

than next objetive is to move higher towards #Fibonacci extension

18.07%(1704)

#Probability

#IEX-700

New Story above 6.857%(718.75)

Projection ploted on chart. in that case base case 521 For near term.#Probability pic.twitter.com/b1PCa0NjI0
— Waves_Perception(Dinesh Patel) \u092e\u0948\u0902Schedule Tribes) (@idineshptl) October 8, 2021

Finterest Capital
@FinterestC

Ion Exchange (India) Limited - A Thread

1/ About the Company
Ion Exchange (India) is engaged in a wide range of solutions across the water cycle from pre-treatment to process water treatment, waste water treatment, recycle, zero liquid discharge, sewage treatment, packaged drinking water, sea water desalination.

2/ Operational Guide
The company operated under three business segments; Engineering segment, Chemicals segment & Consumer Products. Based in Mumbai, the company has seven manufacturing & assembly facilities across India, and one each in Bangladesh, UAE, Bahrain and Indonesia.

3A/ Financial Performance
In FY21:
The overall Sales fell by 2%
6% decline in chemicals
14% fall in consumer products
Engineering had a 0.2% growth
Even after fall in Sales Operating Profits grew by almost 50% YoY (Margin 13.96%)
Net Profit Margin of 9.89%

3B/ Financial Performance
The margins improved based on increased degree of utilization of the clinical setup & improved efficiencies from increased scale of operations
There was favorable movement in raw material prices
The long-term debt reduced from INR 18.8 Cr. to INR 8 Cr

$Abhijit Chokshi | Investors \u0915\u093e \u0926\u094b\u0938\u094d\u0924!$

Abhijit Chokshi | Inve...
@stockifi_Invest

Few apps/tools we use for stock research:

1) @Tijori1
2) @mystockedge
3) @screener_in
4) @TickertapeIN
5) @Trendlyne
6) @Investopedia
7) @moneycontrolcom
8) Research Bytes
9) Google Finance
10) Valuepickr

Do comment below with a tool/app that you use the most for research.

$TradingView India \U0001f1ee\U0001f1f3$

TradingView India 🇮🇳...
@in_tradingview

#IEX - BULLISH VIEW ON IEX - TradingView -

An irony of facebook's situation.

Sheryl got her MBA at Harvard. One of the most famous cases (Extra Strength Tylenol) in one of the most famous classes (Business History) she took: in 1982, someone put cyanide in Extra Strength Tylenol capsules and killed 7 people in Chicago.

What do you do when someone turns your product into a weapon? When they use the system you built to harm? James Burke, CEO of J&J, was shockingly open with the public, he pulled the product and made significant packaging changes to make product safer (but not tamper-proof).

He over-shared every step along the way re investigation, redesign, stood up as both CEO and human. The reintroduction of new Extra Strength Tylenol succeeded. Burke saved the brand.

But four years later it happened again. A killer put cyanide in the capsules, this time a woman in Yonkers died. Same CEO, Burke, pulled the product again, completely changed the form factor from capsule to caplet and relaunched *again*. It worked *again*. How'd they do that?

Burke (CEO) tapped J&Js goodwill bank account w/ the public. Two big withdrawals from that bank account in four years + 8 dead bodies! But his honesty, openness, humanity (choked up about the deaths more than once), humility kept the goodwill bank balance positive the whole time.

Patrick McKenzie
@patio11

So the cryptocurrency industry has basically two products, one which is relatively benign and doesn't have product market fit, and one which is malignant and does. The industry has a weird superposition of understanding this fact and (strategically?) not understanding it.

If everyone was holding bitcoin on the old x86 in their parents basement, we would be finding a price bottom. The problem is the risk is all pooled at a few brokerages and a network of rotten exchanges with counter party risk that makes AIG circa 2008 look like a good credit.
— Greg Wester (@gwestr) November 25, 2018

The benign product is sovereign programmable money, which is historically a niche interest of folks with a relatively clustered set of beliefs about the state, the literary merit of Snow Crash, and the utility of gold to the modern economy.

This product has narrow appeal and, accordingly, is worth about as much as everything else on a 486 sitting in someone's basement is worth.

The other product is investment scams, which have approximately the best product market fit of anything produced by humans. In no age, in no country, in no city, at no level of sophistication do people consistently say "Actually I would prefer not to get money for nothing."

This product needs the exchanges like they need oxygen, because the value of it is directly tied to having payment rails to move real currency into the ecosystem and some jurisdictional and regulatory legerdemain to stay one step ahead of the banhammer.